‘NGF37‘, the cosmetic brand of Medipost, one of the leading companies in Korea for stem cell drugs, was introduced in the LA Times on April 9.
Medipost, which is leading the development of stem cell treatment drugs in Korea, was introduced as the leading bio business in Korea. Also, it is said that Medipost NGF37 is very loved by Korean consumers by combining concentrated stem cell technology in cosmetics and opening a new chapter for the K-beauty and Cosmeceutical (cosmetics + pharmaceutical) markets.
Medipost launched ‘NGF37’, a cosmetic brand containing stem cell conditioned media, in November last year, and was sold out at the TV home shopping show several times in a row.
‘NGF37 Total Solution Synergy Ampoule’ contains 70,000ppm of human cord blood stem cell conditioned media mixed together with other patented plant extracts. It is receiving attention due to its higher content of stem cell conditioned media than other stem cell cosmetics on home shopping. Moreover, its safety and efficacy have been proven through human testing on 15 criteria as well as through hypoallergenic testing.
Especially, with the increasing concern of fine dust and yellow dust these days, it attracts a lot of attention due to its reinforcement of skin barriers and improvement of skin damage by external stimulus and calming effects. It can also help skin damage caused by ultraviolet rays in summer as a bio cosmetic that offer various anti-aging solutions such as improved skin texture and skin elasticity, brushing. ‘Total Solution Synergy Ampoule’ is a real ‘total solution’ product that provides solutions to these various skin concerns at once, and that is why it has been loved ever since it was launched.
Thanks to the hot consumer interest introduced in the LA Times, Medipost NGF 37 has continued to sell its TV home shopping network five months after its launch. The 10th broadcast, scheduled for April 11, is also expected to introduce a new product called ‘NGF37 Total Solution Radiance Cream’ with a new configuration.